Skip to main content

Table 2 Medication profiles of the VDIS subjects (N = 1006)

From: Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study

Medication Regimen

N

Proportion of population, %

Excellent control (A1C < 7%), %

Mean A1C, %

Categorized by number of medications

   No diabetes medications

242

25

80

6.5

   Monotherapy

402

40

58

7.2

   2 Drugs

254

25

46

7.4

   3 Drugs

103

10

29

7.6

   4 Drugs

5

< 1

0

9.2

Categorized by type of medication

   Any oral medication

670

67

51

7.3

   Oral medication(s) alone

578

58

54

7.2

   Any insulin therapy

186

19

35

7.8

   Insulin alone

94

9

41

7.6

   Both oral medication and insulin

92

9

29

7.9

Monotherapy regimen detail

   Sulfonylurea

123

12

58

7.1

   Metformin

126

13

66

7.1

   TZD

55

5

67

6.8

   Insulin

94

9

41

7.6

2-Drug Oral Combination detail

   Sulfonylurea + Metformin

103

10

41

7.5

   Sulfonylurea + TZD

49

5

49

7.2

   Metformin + TZD

50

5

60

7.1

3 Drug Oral Combination detail

   Sulfonylurea + Metformin + TZD

67

7

35

7.4

Insulin therapy detail

   Insulin glargine

90

9

30

8.0

   Any insulin + 1 oral agents

54

5

38

7.8

   Any insulin + 2 oral agents

23

2

20

7.9